Please activate JavaScript!
Please install Adobe Flash Player, click here for download


REFERENCES 1. Bartley, T.D., Bogenberger, J., Hunt, P., Li,Y.S., Lu, H.S., et al. (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor mpl. Cell, 77, 1117–1124. 2. Cazzola, M. and Skoda, R.C. (2000) Translational pathophysiology: a novel molecular mechanism of human disease. Blood, 95, 3280–3288. 3. Coers, J., Ranft, C., and Skoda, R.C. (2004) A Truncated Isoform of c-Mpl with an Essential C-terminal Peptide Targets the Full-length Receptor for Degradation. J Biol Chem, 279, 36397–36404. 3. Damashek, W. (1951) Some speculations on the myeloproliferative syndromes. Blood, 6, 372. 4. de Sauvage, F.J., Carver-Moore, K., Luoh, S.M., Ryan, A., Dowd, M., Eaton, D.L. and Moore, M.W. (1996) Physiological regulation of early and late stages of mega- karyocytopoiesis by thrombopoietin. J Exp Med, 183, 651–656. 5. de Sauvage, F.J., Hass, P.E., Spencer, S.D., Malloy, B.E., Gurney, A.L., Spencer, S.A., Darbonne, W.C., Henzel, W.J., Wong, S.C., Kuang, W.J., Oles, K.J., Hultgren, B., Solberg, L.A., Goeddel, D.V., and Eaton, D.L. (1994) Stimulation of megakar- yocytopoiesis and thrombopoiesis by the c-mpl ligand. Nature, 369, 533–538. 6. Debili, N., Wendling, F., Katz, A., Guichard, J., Breton-Gorius, J., Hunt, P., and Vainchenker, W. (1995) The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood, 86, 2516–2525. 7. Ghilardi, N. and Skoda, R.C. (1999) A single-base deletion in the thrombopoietin (TPO) gene causes familial essential thrombocytosis through a mechanism of more efficient translation of TPO mRNA [letter]. Blood, 94, 1480–1482. 8. Ghilardi, N., Wiestner, A., Kikuchi, M., Oshaka, A., and Skoda, R.C. (1999) Hereditary thrombocythemia in a Japanese family is caused by a novel point mut- ation in the thrombopoietin gene. Br. J. Haematol., 107, 310–316. 51